Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2025 Earnings Call Transcript May 5, 2025
Operator: Good day, everyone, and welcome to the Syndax First Quarter 2025 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions] At this time, I’d like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Sharon Klahre: Thank you, operator. Welcome, and thank you all for joining us today for a review of Syndax’s first quarter 2025...
